PHILADELPHIA, March 01, 2021 (GLOBE NEWSWIRE) — Kehoe Law Firm, P.C. is investigating potential
on behalf of investors of
Athenex, Inc. (“Athenex” or the “Company”) (
to determine whether the Company engaged in securities fraud or other unlawful business practices.
Shares of Athenex dropped significantly after the Company reported Q4 results and received a complete response letter from the FDA expressing concerns about the Company’s new drug application for a drug which treats metastatic breast cancer.
INVESTORS WHO PURCHASED, OR OTHERWISE ACQUIRED, ATNX SECURITIES AND SUFFERED LOSSES GREATER THAN $50,000 ARE ENCOURAGED TO COMPLETE KEHOE LAW FIRM’S
SECURITIES CLASS ACTION QUESTIONNAIRE
OR CONTACT KEVIN CAULEY, DIRECTOR, BUSINESS DEVELOPMENT, (215) 792-6676, EXT. 802,
, TO DISCUSS THE
SECURITIES CLASS ACTION INVESTIGATION OR POTENTIAL LEGAL CLAIMS.
Kehoe Law Firm, P.C.
, with offices in New York and Philadelphia, is a multidisciplinary, plaintiff–side law firm dedicated to protecting investors from securities fraud, breaches of fiduciary duties, and corporate misconduct. Combined, the partners at Kehoe Law Firm have served as Lead Counsel or Co-Lead Counsel in cases that have recovered more than $10 billion on behalf of institutional and individual investors.
This press release may constitute attorney advertising.